Vol 2003, No 33 (2003)

Table of Contents

Research & Development

Pharmacopeia Signs Two Collaborative R&D Deals Abstract pdf
Business Review Editor

Licensing

King Acquires Elan’s US Primary Care Business Abstract pdf
Business Review Editor
GSK Licenses Rights to Preclinical HIV Compound Abstract pdf
Business Review Editor
Watson Pharmaceuticals Enters Agreement for Novartis’ Headache Treatments Abstract pdf
Business Review Editor

General

SkyePharma’s Deal Strategy Abstract
Business Review Editor
Drug Delivery Alliance Development Process Abstract
Business Review Editor
Therapy Focus: Age-related Macular Degeneration Abstract
Business Review Editor

Mergers & Acquisitions

Roche to Bid US$1.2 B for Diabetes Firm, Disetronic Abstract pdf
Business Review Editor
CAT and OGS in US$176 M Merger Abstract pdf
Business Review Editor
J&J to Acquire Scios Abstract pdf
Business Review Editor

Company Profile

SkyePharma plc Abstract pdf
Business Review Editor

Distribution & Marketing

Schering AG to Market Campath® in South East Asia Abstract pdf
Business Review Editor
SkyePharma Licenses Further Solaraze Rights to Shire; Makes Investment in Micap Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.